Introduction {#s1}
============

Ca^2+^-triggered neurotransmitter release by synaptic exocytosis is an exquisitely regulated process for interneuronal communication. The core machinery governing the process includes the SNAREs synaptobrevin, syntaxin-1 and SNAP-25, which form tight SNARE complexes to bridge synaptic vesicles to the plasma membrane and catalyze membrane fusion ([@bib18]; [@bib39]; [@bib44]). Syt1, the Ca^2+^ sensor for the fast component of Ca^2+^-triggered release ([@bib6]; [@bib11]; [@bib13]), confers Ca^2+^ sensitivity to SNARE-dependent synaptic vesicle fusion. The triggering function of Syt1 depends on its interplay with membranes, SNAREs, complexins and other key proteins of the release machinery ([@bib34]).

Syt1 consists of two C2 domains, known as C2A and C2B. The C2A and C2B domains adopt similar structures and bind three and two Ca^2+^ ions, respectively, through their Ca^2+^-binding loops located at the top of the structures ([@bib10]; [@bib36]; [@bib38]). These loops mediate penetration of Syt1 C2 domains to acidic membranes containing phosphatidylserine (PS) in response to Ca^2+^, and this activity is required for the triggering function of Syt1 ([@bib5]; [@bib11]; [@bib33]). In addition, Syt1 readily binds to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) via its C2B domain in a Ca^2+^-independent manner, which helps increase the apparent Ca^2+^ affinity of Syt1 and thereby enhances release probability ([@bib2]; [@bib22]; [@bib32]; [@bib41]). Furthermore, Syt1 binds to SNAP-25 and syntaxin-1, and to SNARE complexes mainly through its C2B domain, which is believed to position Syt1 on the pre-fusion SNARE complexes to trigger release in response to Ca^2+^ ([@bib4]; [@bib48]; [@bib8]; [@bib28]).

Although the biochemical properties of Syt1 have been studied in detail, the functional importance of individual properties has remained unclear. It has been found that disrupting Ca^2+^ binding to C2B impairs release much more strongly than disruption of C2A Ca^2+^ binding sites in vivo ([@bib24]; [@bib29]; [@bib35]).Moreover, previous work showed that isolated C2B, instead of C2A, can promote SNARE-dependent membrane fusion in response to Ca^2+ ^in vitro ([@bib12]; [@bib46]). These findings suggested that C2B plays a more preponderant role than C2A in neurotransmitter release. A number of studies have revisited this issue and suggested that the functional importance of C2B arises partly from its ability to deform membranes. For instance, C2B can induce vesicle clustering and/or membrane curvature in response to Ca^2+^ ([@bib1]; [@bib26]; [@bib16]; [@bib46]). However, it is unclear why C2B has such membrane-deformation activity while C2A does not, given the fact that both C2 domains of Syt1 exhibit similar Ca^2+^-dependent membrane-insertion properties in vitro.

Another potential reason for the striking functional asymmetry of the Syt1 C2 domains was provided by recent studies showing that interactions between C2B and SNARE complexes are crucial for the function of Syt1 in neurotransmitter release ([@bib48]; [@bib4]). However, these studies have yielded conflicting results. For instance, a recently solved Syt1--SNARE complex crystal structure showed a relatively large binding interface between Syt1 and the SNARE complex that involves two basic residues (Arg398 and Arg399, referred to as the R398 R399 region, see [Figure 1A](#fig1){ref-type="fig"}) on the bottom of C2B ([@bib48]), whereas another dynamic Syt1--SNARE complex structure model obtained by nuclear magnetic resonance (NMR) indicated a SNARE binding interface that is located on the polybasic patch (Lys326 and Lys327, referred to as the K326 K327 region, see [Figure 1A](#fig1){ref-type="fig"}) at the side of C2B ([@bib4]). Moreover, both of these basic regions have been previously implicated in binding to acidic membrane lipids, such as PS and PI(4,5)P2 ([@bib46]; [@bib41]). Some other reports argued against the interaction between Syt1 and the SNARE complex, and suggested that the triggering function of Syt1 requires specific binding of C2B to acidic membranes rather than binding to SNARE complexes ([@bib14]; [@bib31]). Taken together, although it seems clear that C2B can interact with either acidic SNARE complexes or acidic membranes due to the abundance of highly positive charges around its surface ([Figure 1B](#fig1){ref-type="fig"}), the binding mode of C2B with SNARE complexes and membranes underlying the actual mechanism of Syt1 in release remains elusive.10.7554/eLife.14211.003Figure 1.Overview of the structure features of Syt1 C2 domains and the core SNARE complex.(**A** and **B**) Structural diagrams (**A**) and electrostatic surface potential (**B**) of Syt1 C2A (PDB entry 1BYN) and C2B (PDB entry 1TJX) domain. Residues K326 and K327 on the side, R398 and R399 on the bottom, and Ca^2+^ ions on the top of C2B are shown as blue and yellow spheres, respectively. Black boxes display the basic patches that include the residues shown in **A**. (**C** and **D**) Structural diagram (**C**) and electrostatic density map (**D**) of the core SNARE complex (PDB entry 1N7S). Residues D51, E52 and E55 are displayed as red spheres. Black box displays the acidic patch, which includes the residues shown in **C**. Syx, syntaxin-1; SN25, SNAP-25; Syb, synaptobrevin-2. The electrostatic surface potential was calculated by generating local protein contact potential (pymol software) and scaled from -5kT/e to 5kT/e, with red and blue denoting negative and positive potential, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.003](10.7554/eLife.14211.003)

To address these conundrums, we systematically investigated the binding properties of the C2B domain with SNARE complexes and membranes using diverse biophysical techniques. Our results showed that, prior to the Ca^2+^ signal, the C2B domain interacts with PI(4,5)P2 and membrane-anchored SNARE complexes through the K326 K327 region and the R398 R399 region, respectively. We also found that the two interactions persist during insertion of the Ca^2+^-binding loops into the membrane upon Ca^2+^ influx. Consistent with a Syt1 triggering model proposed recently by Brunger and colleagues ([@bib48]), our data suggest that the local membrane deformation driven by the C2B domain constitutes a key step for triggering fusion.

Results {#s2}
=======

C2B interacts with SNARE complexes and acidic membranes in the absence of Ca^2+^ {#s2-1}
--------------------------------------------------------------------------------

As mentioned above, Syt1 C2B contains two highly basic regions at the side and the bottom of the structure (i.e., the K326 K327 and R398 R399 regions; see [Figure 1A,B](#fig1){ref-type="fig"}); both regions have been implicated in interactions with the SNARE complex ([@bib4]; [@bib48]). Conversely, an acidic patch located in the middle portion of the SNARE complex (e.g., residues D51, E52, and E55 on SNAP-25, likely with adjacent residues on syntaxin-1, see [Figure 1C,D](#fig1){ref-type="fig"}) has been suggested to mediate binding to C2B ([@bib4]; [@bib28]; [@bib48]). Using the GST pull-down assay, we first re-examined interactions between the two basic regions on C2B and the acidic patch on the assembled SNARE complex in the absence of Ca^2+^. Consistent with previous results ([@bib4]), we found that both C2AB (soluble fragment of Syt1 harboring C2A and C2B) and C2B bound to assembled SNARE complexes, whereas C2A did not ([Figure 2A,B](#fig2){ref-type="fig"}, note that the C2A binding might be too weak to be detected on the gel). The SNARE complex containing the SNAP-25 D51A/E52A/E55A mutation (referred to as SN25 3M) showed impaired binding ability to C2B ([Figure 2A,B](#fig2){ref-type="fig"}), in agreement with previous findings ([@bib4]; [@bib28]; [@bib48]). Note that the SNARE complex bearing SN25 3M was less resistant to SDS ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), yet its assembly was normal ([Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}). As expected, disruption of the C2B Ca^2+^-binding sites (D363N/D365N, referred to as C2b) caused no effect on the SNARE complex binding ([Figure 2A,B](#fig2){ref-type="fig"}). However, disruption of either the K326 K327 region or the R398 R399 region (K326A/K327A, K326E/K327E or R398Q/R399Q, referred to as C2B~2KA~, C2B~2KE~ or C2B~2RQ~, respectively) impaired binding of C2B to the SNARE complex ([Figure 2A,B](#fig2){ref-type="fig"}), indicating that both basic regions of C2B contribute to the SNARE complex binding. This data reproduced previously contradictory findings ([@bib4]; [@bib48]), suggesting heterogeneous interactions between C2B and the SNARE complex in solution ([@bib31]).10.7554/eLife.14211.004Figure 2.Different Ca^2+^-independent interactions of Syt1 with membranes and SNARE complexes.(**A** and **B**) Binding of Syt1 soluble fragments and their mutants to the core SNARE complex measured by GST pull-down assay (**A**) and quantification of the C2B binding (**B**). Asterisks in **A** show the bands of bound protein. 3M, GST-tagged SNARE complex bearing the SNAP-25 D51A/E52A/E55A mutation; H3, the SNARE motif of syntaxin-1; neg.ctrl., negative control, which represents C2B bound to GST-H3. Representative gel from one of three independent experiments is shown. Data are processed by Image J (NIH) and presented as the mean ± SD (n = 3), technical replicates. (**C**) Schematic diagram of the liposome co-flotation assay. After centrifuging, liposomes (orange) and bound proteins (blue) were co-floated on the top of the density gradients, remaining unbounded proteins left in the bottom of the gradients. (**D** and **E**) Co-flotation of C2AB, C2B and their mutants with liposomes bearing 1% PI(4,5)P2 in the absence of Ca^2+^ (**D**) and quantification of the binding (**E**). WT/2RQ/2KA/2KE, Syt1 C2AB or C2B, and the mutants bearing R398Q/R399Q, K326A/K327A or K326E/K327E mutations, respectively; S, supernatant; P, pellet formed by centrifuging. Representative gel from one of three independent experiments is shown. Data are processed by Image J (NIH). (**F** and **G**) FRET between NBD labeled Syt1 C2B-H315C and rhodamine labeled liposomes with or without 1% PI(4,5)P2 (**F**) and quantification of the emission fluorescence of rhodamine at 587 nm (**G**). Liposome compositions are presented below the diagram; all reactions were performed in the absence of Ca^2+^. (**H**) C2B-induced liposome clustering measured in the presence of SNARE complexes. The change in particle size as a function of the C2B concentration was measured by dynamic light scattering (DLS). All data plots are presented as the mean ± SD (n = 3), technical replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.004](10.7554/eLife.14211.004)10.7554/eLife.14211.005Figure 2---figure supplement 1.The SNAP-25 3M mutation displayed less resistance to SDS and no influence on SNARE complex assembly.(**A**) Assembled GST-tagged SNARE complexes were analyzed by SDS-PAGE before pull-down assays. (**B**) The assembly of pre-assembled syntaxin-1--SNAP-25 complex and synaptobrevin monitored by fluorescence anisotropy. (**C**) The assembly of syntaxin-1, SNAP-25 and synaptobrevin monitored by fluorescence anisotropy. Fluorescent probe (BODIPY FL) was labeled on synaptobrevin S61C. The small difference between WT and 3M in B is insignificant given the noise in the traces. WT, wild type; 3M, SN25 D51A/E52A/E55A mutations; neg.ctrl., negative control, which represents the addition of excess unlabeled synaptobrevin.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.005](10.7554/eLife.14211.005)10.7554/eLife.14211.006Figure 2---figure supplement 2.PS-containing liposome clustering induced by C2B and its mutants in the presence of Ca^2+^.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.006](10.7554/eLife.14211.006)

This heterogeneous binding might be due to the absence of membrane lipids. PI(4,5)P2 selectively localizes to the plasma membrane, binds to Syt1 and plays crucial functions in neurotransmitter release ([@bib42]). Using a liposome co-flotation assay ([Figure 2C](#fig2){ref-type="fig"}), we found that, in the absence of Ca^2+^, both C2AB and C2B (wild type, WT) bound efficiently to liposomes containing 1% PI(4,5)P2 ([Figure 2D,E](#fig2){ref-type="fig"}). This PI(4,5)P2-binding ability of Syt1 relies on the K326 K327 region but not the R398 R399 region, as C2AB~2KE~/C2AB~2KA~ or C2B~2KE~/C2B~2KA~ completely abolished binding to PI(4,5)P2-containing liposomes whereas C2AB~2RQ~ or C2B~2RQ~ did not ([Figure 2D,E](#fig2){ref-type="fig"}). To confirm this binding preference, we measured the fluorescence resonance energy transfer (FRET) between 7-nitrobenz-2-oxa-1,3-diazole (NBD) labeled C2B and rhodamine-labeled liposomes ([@bib15]) containing 1% PI(4,5)P2 in the absence of Ca^2+^. When NBD was placed close to the K326 K327 region (H315C-NBD), we detected a robust energy transfer ([Figure 2F,G](#fig2){ref-type="fig"}). Comparably, Ca^2+^-independent FRET signals were considerably weaker when PI(4,5)P2 was removed from liposomes ([Figure 2F,G](#fig2){ref-type="fig"}). The addition of excess assembled SNARE complexes in the reaction caused no obvious effect on the FRET between C2B and PI(4,5)P2-containing liposomes ([Figure 2F,G](#fig2){ref-type="fig"}). These results, together with a recent finding that Syt1 binds to PI(4,5)P2-containing liposomes in physiological ionic conditions that contain ATP and Mg^2+^ ([@bib31]), suggest that the K326 K327 region binds specifically to PI(4,5)P2-containing membranes in the absence of Ca^2+^.

Given that the side K326 K327 region of C2B binds specifically to PI(4,5)P2 on membranes, we explored whether the bottom R398 R399 region tends to bind the SNARE complex. Previous studies suggested that the R398 R399 region binds acidic membranes (i.e., PS) and participates in liposome clustering ([@bib1]; [@bib46]). In our study using PS-containing liposomes, we indeed found that C2B clustered liposomes in response to Ca^2+^ ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Both C2B~2RQ~ and C2b failed to cluster liposomes, while C2B~2KE~ was able to cluster liposomes ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), supporting the idea that the bottom R398 R399 region and the top Ca^2+^-binding loops associate two opposite acidic membranes in response to Ca^2+^ ([@bib46]). However, it is noteworthy that the PS-containing liposomes used in these experiments lacked the SNAREs ([@bib1]; [@bib46]). We therefore re-analyzed the liposome-clustering activity of C2B in the presence of soluble SNARE complexes, as a function of the concentrations of C2B. Robust clustering was observed as the C2B concentration increased in the presence of 1 mM Ca^2+^ ([Figure 2H](#fig2){ref-type="fig"}). To our surprise, the addition of 10 μM soluble SNARE complexes in the reaction strongly impaired liposome clustering but the clustering was capable of gradually recovery as the concentration of C2B exceeded that of SNARE complexes (when C2B was above 10 μM, [Figure 2H](#fig2){ref-type="fig"}). Thus, the likely explanation is that the weaker R398 R399--PS interaction can be replaced by the stronger R398 R399--SNARE complex binding. These results suggest that the R398 R399 region binds preferentially to SNARE complexes rather than acidic membranes.

Persistence of C2B (R398 R399)--SNARE complex interaction in the presence of ATP and Mg^2+^ {#s2-2}
-------------------------------------------------------------------------------------------

We further directly measured the C2B (R398 R399)--SNARE complex interaction using a bimane-tryptophan quenching assay in the absence of membranes. The bimane-tryptophan quenching assay has been previously used to study the structure and movements of proteins and has shown its sensitivity in short-distance electron transfer measurements (\<10 Å) ([@bib17]; [@bib25]; [@bib40]). In this case, a single tryptophan mutation (T285W) at the bottom of C2B that is adjacent to the R398 R399 region was introduced (note that C2B contains two native tryptophans at residues 390 and 404 that are both far from the R398 R399 region, see [Figure 3A](#fig3){ref-type="fig"}). In addition, SNAP-25 was labeled with bimane via a single cysteine mutation (R59C) close to its acidic patch (D51 E52 E55), and was then assembled into the SNARE complex ([Figure 3A](#fig3){ref-type="fig"}). In contrast to a donor only condition (no addition of C2B) and the addtion of C2B (WT), the addition of C2B T285W induced robust quenching of bimane fluorescence on the SNARE complex ([Figure 3B,C](#fig3){ref-type="fig"}). Comparably, C2B T285W containing the R398Q/R399Q mutation (referred to as T285W~2RQ~) showed strongly impaired binding to the SNARE complex, whereas C2B T285W containing the K326E/K327E mutation (referred to as T285W~2KE~) did not have such an effect ([Figure 3B,C](#fig3){ref-type="fig"}). Consistent with previous results ([@bib48]), these data support the specific R398 R399--SNARE complex interaction.10.7554/eLife.14211.007Figure 3.Persistence of the R398 R399--SNARE complex interaction in the presence of ATP and Mg^2+^.(**A**) Schematic diagrams of bimane-labeled SNARE complex and Syt1 C2B. Tryptophan was introduced at the bottom of C2B (T285W, orange stick), which is close to residues R398 and R399; two native tryptophans (W390 and W404) are indicated as red sticks; residues K326 K327 and R398 R399 are shown as blue sticks; Ca^2+^ ions are displayed as yellow spheres. (**B** and **C**) Quenching of bimane fluorescence on the SNARE complex with the addition of C2B T285W and the mutants in the absence of ATP and Mg^2+^ (**B**) and quantification of the results (**C**). (**D** and **E**) Quenching of bimane fluorescence on the SNARE complex with the addition of C2B T285W in the presence of ATP and Mg^2+^ (**D**) and quantification of the results (**E**). Donor only, no addition of Syt1 C2B; T285W, C2B bearing the T285W mutation; T285W~2RQ~ and T285W~2KE~, C2B T285W bearing the R398Q/R399Q or K326E/K327E mutations, respectively. Data are presented as the mean ± SD, technical replicates. n.s., not significant (p \> 0.05); \*p\<0.05; \*\*\*p \< 0.001; one-way ANOVA, n = 5.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.007](10.7554/eLife.14211.007)

We also investigated the R398 R399--SNARE complex interaction in the absence of membranes and in the presence of ATP and Mg^2+^. Robust quenching of bimane fluorescence was still observed with the addition of C2B T285W ([Figure 3D,E](#fig3){ref-type="fig"}), suggesting that the specific R398 R399--SNARE complex interaction persists in a physiological ionic environment. Besides, the K326E/K327E mutation or ATP, but not Mg^2+^, slightly influenced the interaction between the R398 R399 region and the SNARE complex ([Figure 3B--E](#fig3){ref-type="fig"}), likely owing to the electrostatic shielding. This data is inconsistent with a recent study showing that the Syt1--SNARE complex interaction is abolished at conditions containing ATP and Mg^2+^ ([@bib31]). The reason for this contradiction is explained in the Discussion.

Measurement of the binding affinity between C2B and SNARE complexes in the presence of membranes {#s2-3}
------------------------------------------------------------------------------------------------

Since C2B binds to PI(4,5)P2 and the SNARE complex in the absence of Ca^2+^, we measured the binding affinity between C2B and the SNARE complex in the presence of membranes and in the absence of Ca^2+^ by using the bimane-tryptophan quenching assay. Titration of C2B T285W to liposomes containing bimane-labeled *cis*-SNARE complexes yielded a *K*~d~ of 1.53 ± 0.04 μM in the absence of PI(4,5)P2, and a *K*~d~ of 0.86 ± 0.04 μM in the presence of PI(4,5)P2 ([Figure 4](#fig4){ref-type="fig"}), indicating a rather strong interaction between C2B (R398 R399) and the membrane-anchored *cis*-SNARE complex when PI(4,5)P2 is present. This higher binding affinity arises likely because PI(4,5)P2 helps recruit C2B to the membrane through the K326 K327 region and thereby increases the encounter between the R398 R399 region of C2B and the SNARE complex on membranes.10.7554/eLife.14211.008Figure 4.Binding *K*~d~ between C2B and the membrane-anchored SNARE complex.*Cis*-SNARE complexes were reconstituted on liposome via the syntaxin-1 transmembrane domain. PI(4,5)P2 increased the binding affinity between Syt1 C2B and the membrane-anchored SNARE complex in the absence of Ca^2+^. Plots show the quenched efficiency of the bimane-labeled *cis*-SNARE complex reconstituted on liposomes (65% PC + 20% PE + 15% PS) with the titration of Syt1 C2B T285W in the presence (black) and absence (red) of 1% PI(4,5)P2. Diagram in the solid box is the close-up view of the data in the dashed box. Plots are presented as the mean ± SD, technical replicates. \*\*\*p\<0.001; multiple t-test using Holm-Sidak method, n = 5. Non-linear curve fit were achieved by the Michaelis-Menten equation where V~max~ was constrained to 100 (% Quenched efficiency).**DOI:** [http://dx.doi.org/10.7554/eLife.14211.008](10.7554/eLife.14211.008)

Taken together, all above binding results obtained in the absence of Ca^2+^ support the idea that Syt1 \'docks\' two membranes via its transmembrane domain anchored on vesicles and its C2B domain binding to the plasma membrane ([@bib14]; [@bib41]). It is conceivable that C2B pre-adsorbs to the plasma membrane prior to Ca^2+^ influx, through its side K326 K327 region interacting with PI(4,5)P2, and its bottom R398 R399 region binding to surrounding SNAREs (e.g., SNAP-25) or assembled SNARE complexes.

C2B interacts with SNARE complexes and acidic membranes in the presence of Ca^2+^ {#s2-4}
---------------------------------------------------------------------------------

We next sought to explore interactions of C2B with SNARE complexes and membranes in the presence of Ca^2+^ using the liposome co-flotation assay. Previous studies have observed a strong binding of C2B to membranes owing to the insertion of the C2B Ca^2+^-binding loops into PS-containing liposomes in the presence of 1 mM Ca^2+^ ([@bib1]; [@bib15]). However, such strong binding would hinder the detection of interactions of C2B with PI(4,5)P2 or membrane-anchored SNARE complexes at the same time in our co-flotation experiments. To alleviate such an effect, we applied higher ion strength (250 mM KCl, instead of 150 mM KCl used in other experiments throughout the work) and weakened the Ca^2+^-binding loops--Ca^2+^--PS interaction by lowering the concentration of Ca^2+^ from 1 mM to 0.1 mM ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). In the condition containing 250 mM KCl and 0.1 mM Ca^2+^, we could not detect the interaction between C2B and PS-containing liposomes when the SNAREs were absent ([Figure 5A,B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). As such, we could not detect binding of C2B to membrane-anchored *cis*-SNARE complexes in the absence PS or Ca^2+^ ([Figure 5A,B](#fig5){ref-type="fig"}). Efficient binding was only observed when *cis*-SNARE complexes and PS were both present on liposomes in the presence of 0.1 mM Ca^2+^ ([Figure 5A,B](#fig5){ref-type="fig"}). Intriguingly, inclusion of 1% PI(4,5)P2 on liposomes that already contain PS and *cis*-SNARE complexes dramatically enhanced C2B binding in the presence of 0.1 mM Ca^2+^, leaving very little C2B left in the pellet ([Figure 5C,D](#fig5){ref-type="fig"}). In contrast, selective removal of PS, PI(4,5)P2 or *cis*-SNARE complexes on liposomes led to strong impairment of C2B binding ([Figure 5C,D](#fig5){ref-type="fig"}), suggesting a synergy among the C2B (Ca^2+^--binding loops)--Ca^2+^--PS, C2B (K326 K327)--PI(4,5)P2 and C2B (R398 R399)--SNARE complex interactions in the presence of 0.1 mM Ca^2+^.10.7554/eLife.14211.009Figure 5.Synergistic interactions of C2B with membrane-anchored SNARE complexes, PI(4,5)P2 and PS in the presence of 0.1 mM Ca^2+^.(**A** and **B**) Co-flotation of Syt1 C2B with liposomes in the absence of PI(4,5)P2 (**A**) and quantification of the results (**B**). (**C** and **D**) Co-flotation of Syt1 C2B with liposomes in the presence of 1% PI(4,5)P2 (**C**) and quantification of the results (**D**). *Cis*-SNARE complexes were reconstituted on liposome via the syntaxin-1 transmembrane domain. Liposomes compositions in **A** and **C** contain 65% PC, 20% PE, 15% PS with and without 1% PI(4,5)P2. S, supernatant; P, pellet. Representative gel from one of three independent experiments is shown. Data are processed by Image J (NIH) and presented as the mean ± SD (n = 3), technical replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.009](10.7554/eLife.14211.009)10.7554/eLife.14211.010Figure 5---figure supplement 1.Binding of C2B to PS-containing liposomes in different Ca^2+^ concentrations.(**A**) Co-flotation of C2B with liposomes (65% PC + 20% PE + 15% PS) in the presence of 250 mM KCl and different Ca^2+^ concentrations as indicated. (**B**) Quantification of the results in **A**. Representative gel from one of three independent experiments is shown. Data are processed by Image J (NIH) and presented as the mean ± SD (n = 3), technical replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.010](10.7554/eLife.14211.010)

Persistence of both C2B--PI(4,5)P2 and C2B--SNARE complex interactions on membranes in response to Ca^2+^ {#s2-5}
---------------------------------------------------------------------------------------------------------

Next, we characterized the above synergistic interactions in the presence of 1 mM Ca^2+^ and 150 mM KCl in a real-time manner. We first monitored insertion of the Ca^2+^-binding loops into membranes in response to Ca^2+^. For this purpose, we introduced cysteine mutations at the C2B T285W Ca^2+^-binding loop 2 or 3 (T285W N333C or T285W I367C, respectively, see [Figure 6A](#fig6){ref-type="fig"}) and then labeled them separately with NBD and monitored their membrane-insertion abilities. Note that as an environment-sensitive probe, NBD exhibits a large increase in fluorescence intensity when it is transferred from an aqueous to a hydrophobic environment ([@bib7]). In the presence of 1 mM Ca^2+^, addition of either T285W N333C-NBD or T285W I367C-NBD to liposomes containing PS and *cis*-SNARE complexes caused a marked increase in intensity ([Figure 6B,C](#fig6){ref-type="fig"}), confirming that the loops insert into membranes. In contrast, when additional 1% PI(4,5)P2 was applied, both T285W N333C-NBD and T285W I367C-NBD showed even higher intensities ([Figure 6D,E](#fig6){ref-type="fig"}), implying that the membrane-insertion ability of the Ca^2+^-binding loops is enhanced with the assist of the C2B--PI(4,5)P2 interaction. Obviously, compared to T285W N333C-NBD, T285W I367C-NBD exhibited a remarkable enhancement in intensity in response to Ca^2+^ ([Figure 6D,E](#fig6){ref-type="fig"}), suggesting that the loop 3 located on the same side as the K326 K327 region (see [Figure 6A](#fig6){ref-type="fig"}) on C2B is more accessible to membranes. These results imply that the K326 K327 region of C2B persistently sticks to PI(4,5)P2 on the plasma membrane with the insertion of the Ca^2+^-binding loops into membranes. This supports the idea that Ca^2+^-independent pre-adsorption of the K326 K327 region to PI(4,5)P2-harboring membranes helps \'steer\' the Ca^2+^-triggered membrane insertion of Syt1 toward the plasma membrane ([@bib2]).10.7554/eLife.14211.011Figure 6.Persistence of C2B--SNARE complex and C2B--PI(4,5)P2 interactions upon insertion of the Ca^2+^-binding loops into membranes.(**A**) Schematic diagrams of C2B and membrane-embedded *cis*-SNARE complex. NBD was labeled on N333C or I367C (green sticks) on C2B separately; bimane was labeled on SN25 R59C (orange sphere); tryptophan was introduced at the bottom of C2B (T285W, orange stick), which is close to residues R398 and R399; two native tryptophans (W390 and W404) are indicated as red sticks; residues K326 K327 and R398 R399 are shown as blue sticks; Ca^2+^ ions are displayed as yellow spheres. (**B**--**E**) Detecting Ca^2+^-triggered membrane insertion of the Ca^2+^-binding loops using NBD fluorescence reporters in the absence (**B** and **C**) and presence (**D** and **E**) of PI(4,5)P2. Emission spectra were collected from 500 nm to 620 nm. (**F**--**I**) Detecting FRET between tryptophan (T285W) on C2B and bimane-labeled SNARE complexes reconstituted on liposomes in the absence (**F** and **G**) and presence (**H** and **I**) of PI(4,5)P2. Emission spectra were collected from 400 nm to 600 nm. Donor only, no addition of Syt1 C2B.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.011](10.7554/eLife.14211.011)

Meanwhile, we simultaneously monitored the interaction between C2B and membrane-anchored SNARE complexes using the bimane-tryptophan quenching assay when monitoring the C2B Ca^2+^-binding loops inserting into membranes. The addition of T285W N333C-NBD or T285W I367C-NBD induced robust quenching of bimane fluorescence on membrane-anchored *cis*-SNARE complexes under all conditions with or without Ca^2+^ and PI(4,5)P2 ([Figure 6F--I](#fig6){ref-type="fig"}), suggesting that the R398 R399 region binds consistently to the membrane-anchored SNARE complex before and after Ca^2+^ influx. Indeed, crystal structures obtained in the absence and presence of Ca^2+^ produced the same binding interface that involves residues R398 and R399 between Syt1 and the SNARE complex ([@bib48]). Together, these results suggest that the C2B (R398 R399)--SNARE complex interaction is Ca^2+^ independent and this interaction persists during insertion of the Ca^2+^-binding loops into the membrane.

In all, based on the findings that both the R398 R399--SNARE complex interaction and the K326 K327--PI(4,5)P2 interaction persist during entry of the Ca^2+^-binding loops into membranes with PS, it is conceivable that the three simultaneous interactions of C2B induce membrane deformation in response to Ca^2+^ (see the Discussion), as suggested by Brunger and colleagues ([@bib48]).

Ca^2+^-dependent simultaneous C2B--SNARE complex--membrane interactions are crucial for triggering fusion {#s2-6}
---------------------------------------------------------------------------------------------------------

The above results show that the C2B (Ca^2+^--binding loops)--Ca^2+^--PS, C2B (K326 K327)--PI(4,5)P2 and C2B (R398 R399)--SNARE complex interactions occur simultaneously in the presence of Ca^2+^. We next sought to investigate whether all three interactions are required for the triggering activity of C2B in membrane fusion.

It has been widely reported that Syt1 C2AB or C2B can promote SNARE-dependent liposome fusion in response to Ca^2+^ in vitro ([@bib6]; [@bib46]; [@bib26]). However, to what extent the promotion activity of C2AB (or C2B) in vitro reflects the triggering activity of Syt1 in vivo must be interpreted with caution because the liposome-clustering ability of C2AB (or C2B) correlated strongly with its activity in promoting SNARE-dependent liposome fusion ([@bib1]; [@bib15]; [@bib46]). Accelerated liposome fusion might arise from the enhanced membrane docking and SNARE pairing caused by C2AB (or C2B) ([@bib15]). To detect the actual activity of C2AB (or C2B) in triggering fusion, in our liposome fusion system ([Figure 7A,B](#fig7){ref-type="fig"}) we utilized poly-D-lysine as a Ca^2+^-independent factor to mimic liposome docking and increase SNARE pairing ([@bib15]); added complexin-1 to arrest liposomes in a \'ready-for-fusion\' state ([@bib20]; [@bib9]; [@bib21]); and finally applied 1 mM Ca^2+^ to trigger fusion. A lower concentration of C2AB or its mutants (0.5 µM) was applied in the system to avoid liposome clustering.10.7554/eLife.14211.012Figure 7.Ca^2+^-dependent simultaneous C2B--SNARE complex--membrane interactions underlie the function of Syt1 in triggering fusion.(**A** and **B**) Schematic diagrams of the lipid mixing (**A**) and content mixing (**B**) assay. Liposome compositions are presented below the diagram. Cpx, complexin-1. (**C** and **I**) Poly-D-lysine promoted SNARE-dependent lipid mixing (**C**) and content mixing (**I**) in the absence of Ca^2+^. (**D** and **J**) Cpx inhibited SNARE-dependent lipid mixing (**D**) and content mixing (**J**) in the absence of Ca^2+^. (**E** and **K**) C2AB and C2B triggered fast lipid mixing (**E**) and content mixing (**K**) whereas C2A did not in response to Ca^2+^. (**F** and **L**) Disruption of the C2B--SNARE complex--membrane interactions abolished fast lipid mixing (**F**) and content mixing (**L**). (**G** and **M**) The functional analysis of the Ca^2+^-binding loops mutations on C2AB in triggering lipid mixing (**G**) and content mixing (**M**). (**H** and **N**) Quantification of the lipid-mixing (**H**) and content-mixing results (**N**) in **E**--**G** and **K**--**M**, respectively. Data are presented as the mean ± SD (n = 3), technical replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.012](10.7554/eLife.14211.012)10.7554/eLife.14211.013Figure 7---figure supplement 1.Liposome clustering induced by Poly-D-lysine in a concentration-dependent manner.100 μM liposomes (65% PC + 20% PE + 15% PS) mixed with different concentrations of poly-D-lysine were incubated for 40 min and particle size was monitored by DLS. Data plots are presented as the mean ± SEM, technical replicates, degrees of freedom (n) are indicated on the top of the plots.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.013](10.7554/eLife.14211.013)10.7554/eLife.14211.014Figure 7---figure supplement 2.Liposome clustering and SNARE pairing monitored during liposome fusion.(**A**) C2B did not cluster t-liposomes (bearing syntaxin-1--SNAP-25 complex) in the presence of Ca^2+^. Plain liposomes or t-liposomes (59% PC + 20% PE + 20% PS + 1% PI(4,5)P2) bearing 0.5 μM syntaxin-1--SNAP-25 complex or were mixed with 0.5 μM C2B, 1 mM Ca^2+^, after 40 min incubation, particle size of liposomes was monitored using DLS. Data are presented as the mean ± SD, technical replicates. n.s., not significant (p \> 0.05); \*\*\*p\<0.001; two-way ANOVA, n = 5. (**B**) SNARE complexes were largely assembled before Ca^2+^ triggering and not promoted upon Ca^2+^ triggering (1480 s--1500 s). Liposome compositions are indicated below the diagram. 0.2 mM EDTA, complexin-1 (cpx), Syt1 C2B and poly-D-lysine were present all the time unless indicated, Ca^2+^ was added to trigger fusion after 1480 s incubation. BODIPY FL (donor) and TMR (tetramethylrhodamine, acceptor) were labeled on Syb and Syx (D44C, green sphere and S200C, magenta sphere as shown in the schematic diagram, respectively) separately.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.014](10.7554/eLife.14211.014)10.7554/eLife.14211.015Figure 7---figure supplement 3.No leakiness of liposomes detected in the content-mixing experiments.(**A**) Schematic diagram of the normal content mixing and the leakiness control assays. In the leakiness control, both v-liposomes and t-liposomes were loaded with 40 mM sulforhodamine. Liposome compositions are indicated below the diagram. (**B**) Leakiness was not detected in SNARE-dependent content mixing promoted by poly-D-lysine. (**C**) Leakiness was not detected in Ca^2+^-triggered content mixing in the presence of poly-D-lysine, complexin and Syt1 C2AB.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.015](10.7554/eLife.14211.015)

The fusion between liposomes (t-liposomes) reconstituted with syntaxin-1--SNAP-25 complex and synaptobrevin-containing liposomes (v-liposomes) was monitored ([Figure 7A,B](#fig7){ref-type="fig"}) by using a FRET based lipid-mixing and content-mixing assay ([@bib23]; [@bib47]). Consistent with previous observations ([@bib15]), addition of 2 µg/ml poly-D-lysine in the mixtures efficiently induced liposome clustering ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), thereby enhancing SNARE-dependent lipid mixing and content mixing in the absence of Ca^2+^ (in the presence of 0.2 mM EDTA, [Figure 7C,I](#fig7){ref-type="fig"}). This data is consistent with the idea that liposome clustering can promote fusion through facilitating SNARE pairing. Complexin-1 inhibited both lipid mixing and content mixing in the presence of poly-D-lysine and in the absence of Ca^2+^ ([Figure 7D,J](#fig7){ref-type="fig"}), whereas further addition of 1 mM Ca^2+^ at 1500 s triggered both lipid mixing and content mixing ([Figure 7E,K](#fig7){ref-type="fig"}). Consistent with previous studies ([@bib12]; [@bib46]), the triggering activity strictly required C2B instead of C2A ([Figure 7E,K](#fig7){ref-type="fig"}). We emphasize that C2B was unable to cluster SNARE-bearing liposomes at a concentration of 0.5 μM in this fusion system ([Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}), and *trans*-SNARE complexes were mostly assembled at the ready-for-fusion stage arrested by complexin-1 ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}). In addition, SNARE pairing was not obviously promoted during the triggering ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}). These results pinpoint the triggering activity of C2B in membrane fusion. Furthermore, to exclude the possibility that content-mixing signals represented by de-quenching of sulforhodamine fluorescence arise from liposome leakiness, we performed control experiments where both v- and t-liposome were loaded with sulforhodamine ([Figure 7---figure supplement 3A](#fig7s3){ref-type="fig"}). Leakiness was not detected in SNARE-dependent content mixing in the presence of poly-D-lysine with and without C2AB--Ca^2+^ ([Figure 7---figure supplement 3B,C](#fig7s3){ref-type="fig"}), indicating that the real membrane fusion events were observed in our experiments.

Using this system, we investigated whether the simultaneous interactions of C2B with PS, PI(4,5)P2, and the SNARE complex are critical for the triggering activity of C2B. We found that the Ca^2+^-binding sites mutation (C2b) strongly impaired the ability of C2B to trigger both lipid mixing and content mixing in response to Ca^2+^ ([Figure 7F,L](#fig7){ref-type="fig"}). Similar results were obtained when using C2B~2KE~ or C2B~2RQ~ mutations ([Figure 7F,L](#fig7){ref-type="fig"}). These results are consistent with those physiological data in previous studies ([@bib22]; [@bib46]; [@bib48]), suggesting that the simultaneous interactions of C2B with the SNARE complex and membranes are crucial for the triggering function of Syt1.

In addition, we assessed the functional importance of the Ca^2+^-binding loops of C2A *versus* C2B in triggering liposome fusion with this system. We found that disrupting the C2A Ca^2+^-binding sites (D230N/D232N, C2aB) caused a moderate impairment in the lipid mixing and content mixing, whereas disrupting the C2B Ca^2+^-binding sites (D363N/D365N, C2Ab) totally abolished the ability of C2AB to trigger fusion ([Figure 7G,M](#fig7){ref-type="fig"}). Disruption of the Ca^2+^-binding sites on both C2 domains (D230N/D232N/D363N/D365N, C2ab) completely abolished the triggering effect ([Figure 7G,M](#fig7){ref-type="fig"}). Quantification of the lipid-mixing and content-mixing activities of Syt1 and its mutants are shown in [Figure 7H, N](#fig7){ref-type="fig"}. Thus, this fusion system successfully reconstituted the triggering role of C2AB and C2B in vitro and reproduced the relative importance of the C2 domain Ca^2+^-binding sites observed in vivo ([@bib24]; [@bib29]; [@bib35]; [@bib37]).

Actually, previous in vitro studies ([@bib20]; [@bib9]; [@bib48]) have successfully reconstituted the full-length Syt1--SNARE complex machinery at physiological Syt1 copy number and also included complexin-1. To complement these studies, we used the fusion system described in [Figure 7A,B](#fig7){ref-type="fig"} with C2AB replaced by full-length Syt1 (reconstituted on v-liposomes) ([Figure 8A,B](#fig8){ref-type="fig"}). Besides, poly-D-lysine was excluded because full-length Syt1 can \'dock\' two membranes ([@bib41]). We found that Syt1~AB~ (WT) and its mutations on the Ca^2+^-binding sites (Syt1~aB~, Syt1~Ab~ and Syt1~ab~, respectively) all stimulated lipid mixing and content mixing in the absence of Ca^2+^ and complexin-1 ([Figure 8C,F](#fig8){ref-type="fig"}), consistent with the docking role of Syt1. As expected, complexin-1 arrested liposomes bearing Syt1 at the ready-for-fusion stage, and further addition of 1 mM Ca^2+^ at 1500 s triggered fusion ([Figure 8D,G](#fig8){ref-type="fig"}). Consistent with the results observed in our C2AB-based fusion experiments ([Figure 7](#fig7){ref-type="fig"}), Syt1~AB~ and Syt1~aB~ efficiently triggered lipid mixing and content mixing while Syt1~Ab~ and Syt1~ab~ did not ([Figure 8D,E,G,H](#fig8){ref-type="fig"}), verifying the functional importance of the C2B Ca^2+^-binding sites in Ca^2+^-triggered liposome fusion. Note that a physiological ratio of full-length Syt1 and the SNAREs were reconstituted in our experiments ([Figure 8I](#fig8){ref-type="fig"}) as previously reported ([@bib21]; [@bib48]).10.7554/eLife.14211.016Figure 8.Functional analysis of the Ca^2+^-binding loops on full-length Syt1 in triggering liposome fusion.(**A** and **B**) Schematic diagrams of the lipid mixing (**A**) and content mixing (**B**). (**C** and **F**) Syt1 stimulates lipid mixing (**C**) and content mixing (**F**) in the absence of Ca^2+^ and complexin-1 (cpx). (**D** and **G**) The functional analysis of the Ca^2+^-binding loops on Syt1 full-length in triggering lipid mixing (**D**) and content mixing (**G**). (**E** and **H**) Quantification of the lipid-mixing (**E**) and content-mixing results (**H**) in **D** and **G**, respectively. Data are presented as the mean ± SD (n = 3), technical replicates. (**I**) Analysis of reconstituted proteins on liposomes by SDS-PAGE. Mock injection represents the addition of the buffer (no Ca^2+^) instead of CaCl~2~ during triggering.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.016](10.7554/eLife.14211.016)

Discussion {#s3}
==========

Syt1 acts as a Ca^2+^ sensor and plays key functions in neurotransmitter release through its C2 domains. The C2 domains exhibit similar overall structures and Ca^2+^-induced membrane-insertion properties but differ strikingly in their function during release. Despite the fact that the functional significance of the C2B domain in vivo has been successfully reproduced in SNARE-dependent membrane fusion assays in vitro the mechanism by which C2B acts with the SNAREs and membranes to promote fusion is unclear. In the present study, we suggest a membrane-bending property of the C2B domain that arises from its simultaneous interactions with SNARE complexes and membranes. The relevance of our proposed C2B--SNARE complex--membrane interactions is supported by the present study and many previously reported data ([@bib32]; [@bib41]; [@bib48]), concordantly with the increasing realization that Syt1 cooperates with the SNARE complex and membranes in neurotransmitter release.

The functional importance of C2B arises most likely from its unique structure that contains abundant basic residues on its surface, which endows C2B with the ability to bind acidic SNARE complexes and/or membranes. Contiguously electrostatic potentials created by the bottom R398 R399 residues and the side K326 K327 residues of C2B contribute to the SNARE binding, as observed in [Figure 2A,B](#fig2){ref-type="fig"}. However, as demonstrated with our co-flotation and FRET experiments ([Figure 2C--G](#fig2){ref-type="fig"}), the presence of PI(4,5)P2-containing membranes shifts the equilibrium towards an energetically favorable binding where the K326 K327--PI(4,5)P2 interaction dominates. The much higher efficiency of the K326 K327 region, compared to the R398 R399 region, in PI(4,5)P2 binding arises most likely because the K326 K327 region contains a much higher positive-charge density, which enables it to bind tightly to lipid head groups with a highly negative-charge density \[i.e., PI(4,5)P2-microdomains at active zones\] ([@bib14]; [@bib19]; [@bib30]). Consistent with this, further investigations on the C2B--SNARE complex interaction using a more sensitive bimane-tryptophan quenching assay ([Figure 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) indicate that the R398 R399 region of C2B binds to the SNARE complex or the membrane-anchored SNARE complex in a Ca^2+^-independent manner. Thus, the existence of the K326 K327--PI(4,5)P2 interaction and the R398 R399--SNARE complex interaction prior to Ca^2+^ influx likely recruits Syt1 to the fusion sites, which underlies the docking function of Syt1, as suggested previously ([@bib8]; [@bib14]).

A recent report ([@bib31]) argued against the Syt1--SNARE complex interaction because this interaction measured in the study appeared to be completely abolished in the presence of ATP and Mg^2+^. However, Syt1 used in the study was labeled at residue 342, which is close to the polybasic patch, suggesting that this study actually measured the FRET between the K326 K327 region and the SNARE complex, and it is unlikely that it reflects the real Syt1--SNARE complex interaction. Instead, our study found that the R398 R399--SNARE complex interaction persists in the absence and presence of ATP and Mg^2+^ ([Figure 3](#fig3){ref-type="fig"}). It is also noteworthy that C2B T285W and SNAP-25 R59C mutations used in our bimane-tryptophan quenching assay seem unlikely to affect the particular interaction between Syt1 and the SNARE complex, because these residues are outside the \'primary\' interface (interface area: 720 Å^2^; including residues Arg398 and Arg399) between Syt1 and the SNARE complex ([@bib48]). In addition, the C^α^--C^α^ distance between the two labeling sites is measured at \~12 Å based on the Syt1--SNARE complex structures ([@bib48]), consistent with the relatively large effect on the FRET observed in our experiments. Moreover, we measured a reasonably strong binding *K*~d~ \[0.86 ± 0.04 μM and 1.53 ± 0.04 μM in the presence and absence of PI(4,5)P2, respectively\] between C2B and the SNARE complex in the presence of membranes ([Figure 4](#fig4){ref-type="fig"}). Thus, our binding results, together with the observations that both spontaneous and Ca^2+^-evoked release are not affected by the presence of 3 mM ATP ([@bib48]), strongly suggest that the interaction between Syt1 and the SNARE complex is not affected by ionic shielding and is physiologically relevant.

The finding that the R398 R399 region binds preferentially to the SNARE complex in this study seems to be incompatible with our previous studies ([@bib1]; [@bib46]). This discrepancy may arise from the different experimental conditions used between the present work and our previous studies. Re-examination of liposome clustering in a more stringent condition containing abundant SNARE complexes showed that the liposome-clustering ability of C2B is totally abrogated ([Figure 2H](#fig2){ref-type="fig"}). This data suggests that the R398 R399--PS binding might be displaced by the R398 R399--SNARE complex interaction. However, our results could not completely rule out the possibility that a small population of Syt1 molcules act to shorten the distance between membranes via the direct interaction of the R398 R399 region with acidic phospholipids in response to Ca^2+^.

By detecting penetration of C2B into membranes (with PS) as well as binding of C2B to the SNARE complex and PI(4,5)P2 at the same time ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), our results provides acceptable proof for the persistence of the K326 K327--PI(4,5)P2 interaction and the R398 R399--SNARE complex interaction during Ca^2+^ influx. The presence of the simultaneous SNARE-containing membrane binding of the top Ca^2+^-binding loops, of the side K326 K327 region, and of the bottom R398 R399 region, leads to a possible membrane-deformation mechanism of Syt1 ([Figure 9](#fig9){ref-type="fig"}): before Ca^2+^ influx, both the K326 K327--PI(4,5)P2 interaction and the R398 R399--SNARE complex interaction fasten C2B in an orientation parallel with the plasma membrane, leaving the Ca^2+^-binding loops held back from membrane insertion ([Figure 9A](#fig9){ref-type="fig"}); Ca^2+^ influx strongly induces fast insertion of the Ca^2+^-binding loops into membranes, rearranging C2B to an orientation vertical to the plasma membrane. The persistent binding of C2B to PI(4,5)P2 and the membrane-anchored SNARE complex would thus exert a membrane bending force to buck the local membrane outward in response to Ca^2+^ ([Figure 9B](#fig9){ref-type="fig"}). Furthermore, it is likely that binding of C2B to PI(4,5)P2 and SNARE complexes before Ca^2+^ influx would lead to a ring-like arrangement of C2B molecules around the fusion pore ([@bib43]), which would then facilitate bucking local membranes upon collective bending forces in response to Ca^2+^. This possible membrane-deformation mechanism is in good agreement with the Syt1 working model proposed by Brunger and colleagues ([@bib48]), and is supported by a recent observation that local membrane protrusions (5 nm in height, similar to the size of one C2B molecule) bucked on the surface of GUV (giant unilamellar vesicles) require the presence of Syt1 and assembled SNARE complexes ([@bib3]).10.7554/eLife.14211.017Figure 9.A working model of Syt1 in triggering membrane fusion.(**A**) Binding of Syt1 C2B to PI(4,5)P2 and primed *trans*-SNARE complex on the plasma membrane before Ca^2+^ influx. (**B**) The simultaneous interactions of C2B with primed *trans*-SNARE complex and PI(4,5)P2-PS-containing membranes in response to Ca^2+^ cause bucking toward the synaptic vesicle of the plasma membrane. Note that a similar model has been recently proposed ([@bib48]). (**C**) Membrane bucking might cooperate with the action of Syt1 C2B in displacing inhibitory complexin-1 to facilitate the continuous helical SNARE complex assembly, thus triggering membrane fusion and neurotransmitter release. SV, synaptic vesicle; PM, pre-synaptic membrane.**DOI:** [http://dx.doi.org/10.7554/eLife.14211.017](10.7554/eLife.14211.017)

The proposed membrane-deformation mechanism is supported by the finding that all three interactions of C2B are required for the triggering function of the Syt1 in liposome fusion ([Figure 7](#fig7){ref-type="fig"}). This membrane-deformation mechanism explains very well the recent observation that isolated C2B readily bends membranes ([@bib16]), and suggests that membrane insertion of the Ca^2+^-binding loops alone is not sufficient to drive membrane deformation without the assist of the R398 R399 and the K326 K327 regions. Thus, the functional importance of the C2B Ca^2+^-binding sites observed in previous in vivo studies and our present liposome fusion experiments ([Figures 7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}) can be explained: disruption of the C2B Ca^2+^-binding sites abrogates the simultaneous interaction of C2B with acidic membrane lipids \[i.e., PI(4,5)P2 and PS\] and the membrane-anchored SNARE complex, so that the ability of C2B to bend membranes is absolutely abolished. Our data reinforce the idea that local membrane deformation by Ca^2+^--Syt1 is key for the triggering function of Syt1 in release ([@bib16]; [@bib48]). Our data also reinforce the notion that the coordinated efforts of two or more interactions from one protein can induce membrane deformation ([@bib27]).

The liposome fusion results support the notion that SNARE complexes are already partially assembled before Ca^2+^ influx ([Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}), which enables complexin-1 binding and thereby strains such a complex in a stage ready for fusion ([@bib34]). In response to Ca^2+^, C2B-induced membrane bucking would reduce the distance between two apposed membranes, which might cooperate with the action of C2B in displacing inhibitory complexin-1, to facilitate the continuous helical SNARE complex assembly that propagates through the linker region into the transmembrane domains ([Figure 9C](#fig9){ref-type="fig"}). Thus, high curvature stresses induced by C2B and the energy released from the C-terminal SNARE complex assembly might be coupled together in response to Ca^2+^ to overcome the energy barrier for membrane fusion. It is noteworthy that C2A would have an ancillary role by binding to one membrane and helping to dictate the apparent Ca^2+^ affinity of Syt1 ([@bib35]; [@bib48]). Altogether, our results add increasing evidence for the triggering mechanism by which Syt1 acts in concert with the SNARE complex and membranes to promote membrane fusion.

Materials and methods {#s4}
=====================

Recombinant protein purification {#s4-1}
--------------------------------

The cytoplasmic domain of rat Syt1 (known as C2AB) used in this study comprises residues 140--421, and the C2A and C2B domains comprise residues 140--266 and 270--421, respectively. All Syt1 fragments or their mutants, full length rat synaptobrevin-2 and its cytoplasmic domain (residues 29--93), the H3 domain of rat syntaxin-1a (residues 191--253) and full-length rat complexin-1 were constructed into pGEX-6p-1 vector (GE Healthcare; Piscataway, NJ); full-length rat Syt1 (all cysteines were mutated to alanine except the cysteine residue at position 277), rat C-terminal syntaxin-1a (residues 183--288, without Habc domain), full-length human SNAP-25a (with its four cysteins mutated to serines) and SNAP-25a 3M (D51A/E52A/E55A) were constructed into pET28a vector (Novagen; Australia); rat syntaxin-1a C-terminal (residues 183--288, without Habc domain) and human SNAP-25a (with its four cysteins mutated to serines) or SNAP-25a 3M were constructed into pETDuet-1 vector (Novagen). All the recombinant proteins above were expressed in *E.coli* BL21 DE3 cells and purified as previously described ([@bib21]; [@bib23]; [@bib41]). Point mutations were prepared by using the QuickChange Site-Directed Mutagenesis Kit (Agilent Technologies; Santa Clara, CA).

GST pull-down assay {#s4-2}
-------------------

Purified GST-H3 (residues 191--253 of syntaxin-1a) was incubated with SNAP-25 or SNAP-25 3M (SN25 3M) and synaptobrevin (residues 29--93) overnight and analyzed by SDS-PAGE to confirm the SNARE complex formation. 20 μM GST-SNARE complex or GST-H3 was mixed with 10 μM Syt1 fragments and 20 μl 50% (v/v) Glutathione Sepharose 4B affinity media (GE Healthcare) to a final volume of 50 μl. After 2 hr gentle shaking at 4°C, beads were washed 3 times using 25 mM HEPES pH 7.4, 150 mM KCl, and 10% glycerol (buffer A). Samples were analyzed by SDS-PAGE. All experiments were performed in the absence of Ca^2+^.

Liposomes preparation {#s4-3}
---------------------

Lipid powder (all from Avanti Polar Lipids; Alabaster, AL) was dissolved in chloroform at a concentration of 10 mg/ml for storage at -20°C, except for brain PI(4,5)P2 (from porcine\'s brain) in chloroform:methanol:water 20:9:1 at 1 mg/ml. Lipids were mixed at the proper ratio as indicated in the figures or legends to a final concentration of 5 mM and dried under nitrogen followed by vacuum for at least 3 hr. Lipid films were dissolved in buffer A containing 0.2 mM Tris (2-carboxyethyl) phosphine (TCEP, Sigma Aldrich; St. Louis, MO) and 1% CHAPS (w/v, Amresco; Solon, OH) and vortexed for 5 min. For preparing proteoliposomes, purified proteins dissolved in 1% CHAPS (w/v) were added into the dissolved lipid films to a final protein-to-lipid ratio of 1:200 (for SNAREs) and/or 1:1000 (for Syt1 full-length), respectively; for plain liposomes, equivalent buffer A containing 1% CHAPS (w/v) was added; after 30 min incubation at room temperature, the mixtures were dialyzed against buffer A containing 0.1 mM TCEP and 1.0 g/L Bio-beads (Bio-Rad; Hercules, CA) at 4°C 3 times. The prepared proteoliposomes were checked using Dynamic Light Scattering (DLS) on a DynaPro Nanostar (Waytt Technology, Santa Barbara, CA) before using.

Liposome co-flotation assay {#s4-4}
---------------------------

Liposome (2 mM total lipids) compositions are indicated in the figures or legends. Liposomes were incubated with 10 μM proteins (±Ca^2+^) in buffer A (unless stated otherwise) for 40 min at room temperature. The liposomes and bound proteins were isolated by flotation on a Histodenz (Sigma Aldrich) density gradients (40%:30%) using a SW 55 Ti rotor (Beckman Coulter; Boulevard Brea, CA) at 163,000 ×g for 40 min. Samples from the top and the bottom of the gradient (20 μl) were taken and analyzed by SDS-PAGE and Coomassie Brilliant Blue (CBB) staining.

Fluorescence measurements {#s4-5}
-------------------------

For liposome-protein FRET experiments ([Figure 2F,G](#fig2){ref-type="fig"}), 100 μM liposomes were mixed with 5 μM Syt1 C2B H315C-NBD and 20 μM soluble SNARE complex. Fluorescence was monitored in a physiological ion condition (buffer A) on a PTI QM-40 fluorescence spectrophotometer (PTI; Edison, NJ) with an excitation wavelength of 460 nm and an emission spectra from 500 to 650 nm.

For bimane-tryptophan electron transfer in the absence of membranes ([Figure 3](#fig3){ref-type="fig"}), 1 μM assembled SNARE complex which harbors monobromobimane (mBBr, Molecular Probes; Eugene, OR) labeled SNAP-25a R59C was mixed with 2 μM Syt1 C2B or its mutant (as indicated in the figures), and additional 1 mM magnesium chloride (analytical grade) and 3 mM ATP (Bio Basic Inc.; Canada) were incorporated as indicated. Fluorescence was monitored on a PTI QM-40 fluorescence spectrophotometer with an excitation wavelength of 380 nm and emission spectra from 400 to 600 nm.

For the *K*~d~ measurement between Syt1 C2B and membrane-anchored SNARE complex in [Figure 4](#fig4){ref-type="fig"}, Syt1 C2B T285W was mixed with 200 μM liposome \[64% POPC, 20% POPE, 15% DOPS and/or 1% PI(4,5)P2, removed PI(4,5)P2 was supplied with POPC\] bearing bimane-labeled SNARE complex (with a protein-to-lipid ratio of 1:200) with indicated concentration. Bimane fluorescence was monitored on a PTI QM-40 fluorescence spectrophotometer with an excitation wavelength of 380 nm and an emission wavelength of 470 nm. Data plots were fitted using the Michaelis-Menten equation, where V~max~ was constrained to 100 (% Quenched efficiency).

For bimane-tryptophan electron transfer and NBD membrane-insertion assay ([Figure 6](#fig6){ref-type="fig"}), 100 μM liposomes (bearing bimane-labeled SNARE complex with syntaxin-1 transmembrane domain anchored on liposomes and with a protein-to-lipid ratio of 1:200) were mixed with 5 μM NBD-labeled Syt1 C2B. A dual excitation of 380 nm (for bimane) and 460 nm (for NBD) and a dual emission spectrum of 400--600 nm and 500--620 nm was used to collect the fluorescence of bimane and NBD, respectively.

Fluorescence anisotropy assay in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} was carried out as previously described ([@bib45]). 200 nM BODIPY FL (Molecular Probes) labeled synaptobrevin (residues 29--93, S61C) was mixed with 1 μM syntaxin-1 (residues 191--253) and SNAP-25 or 1 μM pre-incubated syntaxin-1--SNAP-25 complex.

For the SNARE-pairing assay shown in [Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}, 0.2 mM EDTA, 2 μg/ml poly-D-lysine, 20 μM complexin and 0.5 μM Syt1 C2B were incorporated into a mixture of t-liposome (100 μM lipids and 0.5 μM syntaxin-1 S200C-tetramethylrhodamine \[TMR, Molecular Probes\]-SNAP-25) and v-liposome (50 μM lipids and 0.25 μM synaptobrevin D44C-BODIPY FL) unless otherwise indicated. After incubation for 1480 s, 1 mM Ca^2+^ was added. Donor fluorescence was monitored with an excitation wavelength of 485 nm and an emission wavelength of 513 nm. All lipid compositions are indicated in the figures or legends. All experiments were performed at 25°C in a 1-cm quartz cuvette in buffer A.

Liposome clustering assay {#s4-6}
-------------------------

Liposome clustering assay was carried out as previously described ([@bib1]; [@bib46]). Briefly, 100 μM liposomes were mixed with 1 mM Ca^2+^, with/without 10 μM of a soluble SNARE complex or the equivalent volume of buffer and the indicated concentration of Syt1 C2B was incorporated for 40 min incubation at room temperature. Liposome compositions are indicated in the figures or legends. Particle sizes were analyzed by DLS using a DynaPro Nanostar (Waytt Technology) at 25°C.

Lipid mixing assay {#s4-7}
------------------

General procedures are indicated in [Figure 7A](#fig7){ref-type="fig"} and [Figure 8A](#fig8){ref-type="fig"}. For lipid mixing using the soluble Syt1 fragments, 0.2 mM EDTA, 2 ug/ml poly-D-lysine, 20 μM complexin and 0.5 μM Syt1 fragments were added to a mixture of 100 μM t-liposomes (bearing 0.5 μM syntaxin-1--SNAP-25) and 50 μM v-liposomes (bearing 0.25 μM synaptobrevin). For lipid mixing using reconstituted full-length Syt1, poly-D-lysine was excluded, and v-liposomes (50 μM) were reconstituted with synaptobrevin (bearing 0.25 μM synaptobrevin) and 0.05 μM full-length Syt1 (with a protein-to-lipid ratio of 1:1000). After incubation, 1 mM Ca^2+^ was added to trigger lipid mixing at 1500 s. Donor (NBD) fluorescence were monitored on a PTI QM-40 fluorescence spectrophotometer with an excitation wavelength of 460 nm and an emission wavelength of 538 nm. Fluorescence in [Figure 7](#fig7){ref-type="fig"} was normalized to the initial fluorescence intensity. Fluorescence in [Figure 8](#fig8){ref-type="fig"} were normalized to the fluorescence intensity at 0.1% Triton X-100. All experiments were carried out at 25°C in buffer A. Lipid compositions are indicated in the figures or legends.

Content mixing assay {#s4-8}
--------------------

General procedures are indicated in [Figure 7B](#fig7){ref-type="fig"} and [Figure 8B](#fig8){ref-type="fig"}. 40 mM sulforhodamine B (Sigma) was loaded into v-liposome (harboring synaptobrevin with or without full-length Syt1) without lipid probes. Other details are the same as with lipid mixing assays. Leakiness control was performed with 40 mM sulforhodamine B both loaded into t-liposomes and v-liposomes. Fluorescence was monitored on a PTI QM-40 fluorescence spectrophotometer with an excitation wavelength of 565 nm and an emission wavelength of 580 nm. Fluorescence normalization is the same as that used in the lipid-mixing assay. All experiments were carried out at 25°C in buffer A. Lipid compositions are indicated in the figures or legends. Additional 10% Cholesterol (Chol, from ovine wool, Avanti Polar Lipids) was incorporated into v-liposomes to prevent leakiness.

Statistical analysis {#s4-9}
--------------------

Prism 6.01 (Graphpad) and Image J (NIH) were used for graphing and statistical tests, all of which are described in figure legends.

Funding Information
===================

This paper was supported by the following grants:

-   National Science Foundation of China 31322034 to Cong Ma.

-   National Key Basic Research Program of China 2014CB910203 to Cong Ma.

-   National Key Basic Research Program of China 2015CB910800 to Cong Ma.

We thank Josep Rizo (University of Texas Southwestern Medical Center at Dallas) for providing constructs and insightful advice. We thank Li Yu and Senfang Sui (Tsinghua University) for helpful discussion.

Additional information {#s5}
======================

The authors declare that no competing interests exist.

SW, Conception and design, Acquisition of data, Analysis and interpretation of data.

YL, Acquisition of data, Analysis and interpretation of data.

CM, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

10.7554/eLife.14211.018

Decision letter

Brunger

Axel T

Reviewing editor

Stanford University

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Synaptotagmin C2B domain cooperates with the SNARE complex and membranes to promote fusion\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Richard Aldrich as the Senior Editor. Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work in its present form is not suitable for publication in *eLife*.

There are two topics mixed in this paper: (1) simultaneous/cooperative binding of Syt1-C2B to both SNARE complex and membrane, and (2) enhancement of SNARE complex formation by Munc13 conjunction with Syt1. This work would greatly benefit from splitting these new results into two papers. The reviewers and editors felt that the results on Syt1-C2B-membrane interactions are potentially more interesting than the results on Munc13. Several concerns (as outlined below) were raised by all reviewers which preclude further consideration of the manuscript in its present form.

Reviewer \#1:

This work presents data that suggest that the C2B domain of Syt-1 simultaneously and cooperatively interacts with both the SNARE complex and the plasma membrane prior to Ca^2+^ influx. The results and discussions in this manuscript may clarify previous results in the literature that suggested competition between membrane binding and SNARE complex binding. This work also suggests that Syt1 C2B stimulates Munc18-Munc13-dependent SNARE complex assembly in the absence of calcium.

Comments:

A better discussion of the previous findings by Zhou et al. (2015) should be included in the Introduction and the Discussion: Zhou et al. found that there is a conserved and calcium independent interface between synaptotagmin-1 and the neuronal SNARE complex and that this interface is essential for fast synchronous release in neurons. Moreover, Zhou et al. proposed that the C2B-SNARE complex unit exists prior to calcium binding and then moves as a block, deforming the membrane by simultaneous three interactions with the membrane involving the polybasic region of Syt1, the calcium binding loops of Syt1 C2B, and the membrane anchor and juxtamembrane region of syntaxin and SNAP-25, similar to the model proposed in this manuscript.

In the model [Figure 7](#fig7){ref-type="fig"}, the orientation of the C2B domain is inconsistent with the crystal structure of the primary interface by Zhou et al. (2015) (the C2B domain is rotated by 180 degrees compared to the model shown in [Figure 7](#fig7){ref-type="fig"}). Realizing that the data presented in this manuscript are insufficient to determine the orientation of the C2B domain and the authors probably wrote this paper before the Zhou et al. publication became available, the model should nevertheless be corrected according to the crystal structure in order to avoid confusion.

[Figure 5](#fig5){ref-type="fig"} shows that the C2B -- SNARE interaction is Ca^2+^ independent. This actually has been shown by Zhou et al. since crystal structures in the absence and presence of Ca^2+^ produced the same primary interface between Syt1 and SNARE comple (please cite this in this context); What is new here is that the interaction persists upon insertion of the Ca binding loops into the membrane.

The results presented in this paper are in conflict with the Brewer et al. (NSMB 2015) results. The authors are encouraged to discuss possible reasons for this apparent conflict.

The lipid composition of the co-flotation assay ([Figure 2D](#fig2){ref-type="fig"}) apparently did not include PS, whereas the other experiments (2F, 2H) include 15% PS. Is there a reason that PS was omitted in the experiment shown in [Figure 2D](#fig2){ref-type="fig"}? Ideally, PS should be included in all experiments for consistency.

A recent paper (Park Y, et al. (2015), Nat Struct Mol Biol. doi: 10.1038/nsmb.3097) implies that Syt1 -- SNARE interactions are weak or non-existent at 150 mM KCl, MgCl2 and ATP ([Figure 5](#fig5){ref-type="fig"} in the Park et al. paper). What are the specific salt condition for the various Syt1-SNARE binding experiments in [Figures 2A, C, F, H](#fig2){ref-type="fig"} and [Figure 5F-I](#fig5){ref-type="fig"}? Ideally, the conditions of the Park et al. paper should be tested in the experiments described in [Figures 5F-I](#fig5){ref-type="fig"}.

In Figure panels 3C, D, experiments with the C2B 2KE and 2RQ mutants should be performed, similar to what was done in panels 3E, F.

In [Figure 5](#fig5){ref-type="fig"}, controls should be performed using the K326E, K327E (polybasic -- membrane binding) and R398Q R399Q (SNARE binding) mutants.

[Figure 5](#fig5){ref-type="fig"}: what is the lipid composition of the proteoliposomes?

The bulk assay shown in [Figure 6](#fig6){ref-type="fig"} may be subject to effects caused by vesicle docking and/or lipid mixing since both effects would result in the observed decrease in donor fluorescence. Content mixing assays should be performed.

Reviewer \#2:

The role of patches of basic residues at the side (K326, K327) and bottom (R398, R399) of the synaptotagmin 1 C2B domain on SNARE protein/complex and phospholipid binding have been focus of numerous studies in the recent past, leading to partially conflicting results. This study aims to resolve the SNARE and membrane binding modes of the C2B domain (in absence and presence of Ca^2+^) and how these interactions contribute to the fusion process. The authors utilize a number of techniques GST pulldown, coflotation, fluorescence measurements and in vitro fusion assays to demonstrate that mutation of side and bottom basic residues impair SNARE complex binding and membrane binding in a Ca dependent manner.

This work is based on a large body of literature and the findings presented here are in part confirmatory and in part new.

New is the finding that the interactions of the bottom loop with the membrane can be competitively displaced by the presence of SNARE complexes. Another aspect of the work is that the authors show that synaptotagmin C2B domain is able to double the rate of SNARE complex formation. Perhaps the most interesting aspect is that they can simultaneously monitor both penetration of C2B domain into the membrane and binding to the SNARE complex with the bottom loop at the same time, providing decent proof for the presence of a simultaneous binding of top loops to membranes and bottom loop to cis-SNARE complex via the acid patch created by SNAP25 residues. However, does this experiment exclude that a considerable fraction of the bottom loop would also be able to interact with the phospholipid membrane?

On other issue here is the conversion of positive to negative charges in the mutations: net charge difference particularly in the coflotation assays may be of concern.

*Reviewer \#3:*

This study has important new data, is largely well-written and, in certain respects, presents major advances, especially in [Figure 3](#fig3){ref-type="fig"}.

1\) They \"propose that the membrane bending induced by the fast transition between the two binding modes underlies the \[fusion\] triggering function of C2B\" (from the Abstract), yet there is no measurement of membrane bending nor is there any data which implicates the transition between the two binding modes, as opposed to the binding modes themselves, in causing fusion. They are welcome to make such a model, of course, but should make clearer distinctions between what they show and what is simply hypothesis.

2\) The data in [Figure 6](#fig6){ref-type="fig"} from the classical assay of dequenching between two fluorescent lipids purports to show \"lipid mixing\". However, it has been shown in this journal (Zick and Wickner, *eLife* 2014;3:e09251) that this assay measures trans-SNARE pair dependent events which do not correspond to lipid mixing. In the text, they assume that this lipid mixing is the result of fusion, though it was shown in this same paper that such dequenching can occur in the absence of fusion. The authors should replace this figure with one measuring the mixing of proteoliposomal lumenal contents (in the continuous presence of an external quenching agent, to control for leakage or lysis).

3\) They claim that calcium binding \"...causes a cooperative interaction of C2B with membranes and the SNARE complex.\" The data however show that C2B can bind membranes or SNARE complex independently, with no data showing cooperativity to this binding.

4\) [Figure 2A](#fig2){ref-type="fig"}; they claim that C2B but not C2A binds to SNARE complex, but the C2B band is faint and the C2A band could be just below the detection limit. Also, they claim synergy between the 2 basic regions of C2B for their binding to SNARE complex, but there is no quantitative binding data to gird this claim. What do they mean by synergy here?

5\) Does \"MUN\", as used in [Figure 3](#fig3){ref-type="fig"}, refer to both Munc13 and Munc18? Were these singly omitted, to support the claim that both are needed? I don\'t see this in the figure.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your work entitled \"Synaptotagmin C2B domain interacts simultaneously with SNAREs and membranes to promote fusion\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Richard Aldrich as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is a re-submission of a previous submission to *eLife*. The authors have now focused on Syt1 -- SNARE -- membrane interactions, making this a more accessible and interesting study for the general reader. The authors revisited three proposed key interactions of the Syt-1 C2B domain -- (i) calcium-dependent binding of the calcium binding loops to membranes with PS, (ii) binding of basic residues K326/327 to membranes with PIP2, and (iii) binding of basic residues R398/399 to the SNARE complex. The data indicate that all three interactions occur simultaneously and are all required for the triggering function the Syt-1 C2B domain in liposome/vesicle fusion. The findings reconcile recently published contradictory data on the functional significance of SNARE complex binding by Syt-1 (e.g. Park et al., 2015 vs. Zhou et al., 2015) -- the discrepancy of the present data with those of Park et al. (2015) as regards the ion-sensitivity of the Syt-1-SNARE interaction is explained by differences in the areas labeled for fluorescence/FRET-based interaction studies.

In addition, the authors present new data on the *K~d~* between Syt1 and the SNARE complex in the presence of membrane. To our knowledge this is the first time a reasonably strong *K~d~* has been reported for this interaction (below 1 microM), compared to the relatively weak Syt1-SNARE interaction in the absence of membranes. However, there are a few issues that need to be addressed before acceptance.

Essential revisions:

1\) The pull-down assay shown in [Figure 2A](#fig2){ref-type="fig"} is used as a basis to claim that mutation of the acidic patch in the SNARE complex (SNAP-25 D51/E52/E55 to A -- 3M) abolishes binding to the Syt-1 C2B domain. However, it looks as if there is much less SNARE complex in this assay. The authors claim that this is due to lower SDS-resistance of the 3M complex, but there is no trace of the SNARE monomers on the gel, and there is a (slight) difference in the assembly between the WT and the 3M complex. How can one be sure that the same amount of assembled SNARE complex was added in the assay?

2\) [Figure 3](#fig3){ref-type="fig"}: In their binding assays designed to show the synergistic effects of the three key Syt-1 C2B binding modes, the authors used a condition where the dominant effect of the calcium-dependent interaction is reduced. How sensitive are the interactions to calcium (see also next point)?

3\) [Figure 3](#fig3){ref-type="fig"} implies that there is no interaction between C2B and the membrane-reconstituted SNARE complex in the absence of calcium and absence of PIP2. Yet, [Figure 4 F-I](#fig4){ref-type="fig"} suggests that there is such an interaction in the absence of calcium and presence of PIP2. The authors should attempt a co-flotation experiment using the same conditions as that of [Figure 4F-I](#fig4){ref-type="fig"}, and in the absence of calcium.

4\) [Figure 4](#fig4){ref-type="fig"}: Syt1-T285W and SNAP-25 R59C mutations. The authors should comment in the text that these residues are outside the primary interface between Syt1 and SNARE complex as observed in the crystal structures by Zhou et al. (2015). Thus, these mutations are unlikely going to affect this particular interaction between Syt1 and SNARE complex. This is an important comment since unfortunate placement of labels have affected this interaction in work by others (Brewer et al., 2015; Park et al., 2015). Moreover, the Ca-Ca distance between the two labeling sites is \~ 12 A (based on the structures by Zhou et al.), consistent with the relatively large effect on FRET that the authors observe. Again, this is worth mentioning.

5\) [Figure 6](#fig6){ref-type="fig"}: Was this experiment done in the presence of membrane (i.e., similar to the method shown in [Figure 4F-I](#fig4){ref-type="fig"})?

6\) [Figure 7](#fig7){ref-type="fig"} and second paragraph subsection "Ca^2+^-dependently simultaneous C2B--SNARE complex--membrane interactions are crucial for triggering fusion": The in vitro assay by Kyoung et al., 2011; Diao et al., 2012; Lai et al., 2014) actually reconstituted the full-length Syt1-SNARE machinery at physiological Syt1 copy number and also included complexin. Moreover, Zhou et al. (2015) showed that mutation of the primary interface disrupts calcium-triggered vesicle fusion in this assay. These results should be mentioned in the context of presenting [Figure 7](#fig7){ref-type="fig"} and the authors should point out which aspects of their experiments go beyond the previous results by Zhou et al. (2015) (e.g., the studies of calcium-binding site mutations.

7\) [Figure 7](#fig7){ref-type="fig"}: Based on other work (Wang Z, Liu H, Gu Y, Chapman ER (2011) Reconstituted synaptotagmin I mediates vesicle docking, priming, and fusion. J Cell Biol 195:1159-70. doi: 10.1083/jcb.201104079) the behaviors of the isolated Syt-1 C2B or Syt-1 C2AC2B fragments are different from the behavior of full-length Syt-1. The authors need to validate the findings in [Figure 7](#fig7){ref-type="fig"} that go beyond those of Zhou et al. (2015) by using full-length, reconstituted Syt-1.

8\) [Figure 8](#fig8){ref-type="fig"}: the palmitoylation positions of the SNAP-25 linker region are incorrectly drawn -- they are close to the C-terminal side of the SNARE complex.

9\) Please provide the rationale for the (relative) concentrations of SNAREs, SNARE complexes, and Syt-1 fragments used in the different assays.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Synaptotagmin^-1^ C2B domain interacts simultaneously with SNAREs and membranes to promote membrane fusion\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Richard Aldrich (Senior editor), and two reviewers, one of whom is a member of our Board of Reviewing Editors. The manuscript has been improved but there are some small remaining issues that need to be addressed before acceptance, as outlined below:

1\) Please move the new results with full-length synaptotagmin^-1^ to the main figure and move the results with the soluble C2AB domain ([Figure 7](#fig7){ref-type="fig"}) to a supplement. The results with the full-length protein are more relevant.

2\) Results, paragraph one: \"K326E/K327E, K326E/K327E\" should be \"K326A/K327A, K326E/K327E\".

10.7554/eLife.14211.019

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

There are two topics mixed in this paper: (1) simultaneous/cooperative binding of Syt1-C2B to both SNARE complex and membrane, and (2) enhancement of SNARE complex formation by Munc13 conjunction with Syt1. This work would greatly benefit from splitting these new results into two papers. The reviewers and editors felt that the results on Syt1-C2B-membrane interactions are potentially more interesting than the results on Munc13. Several concerns (as outlined below) were raised by all reviewers which preclude further consideration of the manuscript in its present form.

In the new manuscript, we took out Munc13 results and only focused on the results on C2B--SNARE complex--membrane interactions as suggested by the editors. In addition, we have tried to address most of the concerns the reviewers raised and we have included data from new experiments that were performed based on some of the reviewers' comments. Below I summarize the revisions made and provide answers to other reviewer concerns.

Reviewer \#1:

*This work presents data that suggest that the C2B domain of Syt-1 simultaneously and cooperatively interacts with both the SNARE complex and the plasma membrane prior to Ca^2+^ influx. The results and discussions in this manuscript may clarify previous results in the literature that suggested competition between membrane binding and SNARE complex binding. This work also suggests that Syt1 C2B stimulates Munc18-Munc13-dependent SNARE complex assembly in the absence of calcium. Comments: A better discussion of the previous findings by Zhou et al. (2015) should be included in the Introduction and the Discussion: Zhou et al. found that there is a conserved and calcium independent interface between synaptotagmin^-1^ and the neuronal SNARE complex and that this interface is essential for fast synchronous release in neurons. Moreover, Zhou et al. proposed that the C2B-SNARE complex unit exists prior to calcium binding and then moves as a block, deforming the membrane by simultaneous three interactions with the membrane involving the polybasic region of Syt1, the calcium binding loops of Syt1 C2B, and the membrane anchor and juxtamembrane region of syntaxin and SNAP-25, similar to the model proposed in this manuscript.*

We included the finding by Zhou et al. (2015) in the Introduction and mentioned the model proposed by Zhou et al. (2015) throughout the paper.

*In the model [Figure 7](#fig7){ref-type="fig"}, the orientation of the C2B domain is inconsistent with the crystal structure of the primary interface by Zhou et al. (2015) (the C2B domain is rotated by 180 degrees compared to the model shown in [Figure 7](#fig7){ref-type="fig"}). Realizing that the data presented in this manuscript are insufficient to determine the orientation of the C2B domain and the authors probably wrote this paper before the Zhou et al. publication became available, the model should nevertheless be corrected according to the crystal structure in order to avoid confusion.*

We redrew the Syt1 triggering model (now in [Figure 8](#fig8){ref-type="fig"}) according with the C2B--SNARE complex primary binding interface provided by the Syt1--SNARE complex structure (Zhou., et al. (2015)). The orientation of the C2B domain is thus accordingly corrected by a 180-degrees rotation with respect to the SNARE complex, as suggested by the model proposed by Zhou., et al. (2015).

*[Figure 5](#fig5){ref-type="fig"} shows that the C2B -- SNARE interaction is Ca^2+^ independent. This actually has been shown by Zhou et al. since crystal structures in the absence and presence of Ca^2+^ produced the same primary interface between Syt1 and SNARE comple (please cite this in this context); What is new here is that the interaction persists upon insertion of the Ca binding loops into the membrane.*

We thank the reviewer for reminding us and we cited this paper in the according place.

*The results presented in this paper are in conflict with the Brewer* et al. *(NSMB 2015) results. The authors are encouraged to discuss possible reasons for this apparent conflict.*

As shown in our present study, both the bottom R398 R399 region and the side K326 K327 region of C2B are able to interact with the SNARE complex in solution ([Figure 2A,B](#fig2){ref-type="fig"}), as reported in the literature. Thus, we suppose that interactions between C2B and the SNARE complex in solution are dynamic unless the appearance of acidic membranes. We discussed this issue in the Discussion paragraph two.

*The lipid composition of the co-flotation assay ([Figure 2D](#fig2){ref-type="fig"}) apparently did not include PS, whereas the other experiments (2F, 2H) include 15% PS. Is there a reason that PS was omitted in the experiment shown in [Figure 2D](#fig2){ref-type="fig"}? Ideally, PS should be included in all experiments for consistency.*

As suggested, we re-tested the binding of C2AB/C2B and the mutants with liposomes containing both PIP2 and PS with the co-flotation assay and confirmed that the K326 K327 region mediates the PIP2 binding ([Figure 2D](#fig2){ref-type="fig"}).

*A recent paper (Park Y, et al. (2015), Nat Struct Mol Biol. doi: 10.1038/nsmb.3097) implies that Syt1 -- SNARE interactions are weak or non-existent at 150 mM KCl, MgCl2 and ATP ([Figure 5](#fig5){ref-type="fig"} in the Park et al. paper). What are the specific salt condition for the various Syt1-SNARE binding experiments in [Figures 2A, C, F, H](#fig2){ref-type="fig"} and [Figure 5F-I](#fig5){ref-type="fig"}? Ideally, the conditions of the Park et al. paper should be tested in the experiments described in [Figures 5F-I](#fig5){ref-type="fig"}.*

First, the salt conditions for the Syt1--SNARE binding experiments were 25 mM HEPES pH 7.4, 150 mM KCl, 10% glycerol in [Figure 2](#fig2){ref-type="fig"} and [Figure 4](#fig4){ref-type="fig"}--[6](#fig6){ref-type="fig"}, and was 25 mM HEPES pH 7.4, 250 mM KCl, 10% glycerol in [Figure 3](#fig3){ref-type="fig"}. Second, a recent report (Park Y, et al. (2015)) argues against the physiologically relevant of the Syt1--SNARE complex interaction by showing that this binding is abolished in conditions containing ATP and Mg^2+^ with FRET experiments. However, C2AB used in the study was labeled at residue 342, which is close to the polybasic region, so that this study measured the interaction between the K326 K327 region and the SNARE complex. These data only suggest the competition of ATP/Mg^2+^ with the SNARE complex for the K326 K327 region binding. In addition, Park Y, et al. suggested in their study that the K326 K327 region prefers to PIP2 binding at a physiologically ionic environment. Our data support the notion that K326 K327 region binds to PIP2 ([Figure 2C-G](#fig2){ref-type="fig"}) and showed that the interaction between the R398 R399 region and the SNARE complex persisted even at conditions containing 25 mM HEPES pH 7.4, 150 mM KCl, 10% glycerol, 3mM ATP and 1mM Mg^2+^ ([Figure 6](#fig6){ref-type="fig"}), reinforcing the functional importance of the Syt1--SNARE complex interaction.

*In [Figure 5](#fig5){ref-type="fig"}, controls should be performed using the K326E, K327E (polybasic -- membrane binding) and R398Q R399Q (SNARE binding) mutants.*

In [Figure 5](#fig5){ref-type="fig"} (now in [Figure 4](#fig4){ref-type="fig"}), instead of using the K326E, K327E mutant, we used liposomes that lacked PIP2 as the control because these liposomes lost the ability to bind the K327 K327 region. In addition, we accordingly tested the interaction between the R398 R399 region and the SNARE complex in solution by using the K326E/K327E and R398Q/R399Q mutations ([Figure 6](#fig6){ref-type="fig"}).

*[Figure 5](#fig5){ref-type="fig"}: what is the lipid composition of the proteoliposomes?*

The lipid composition of the proteoliposomes are shown on the top of the panels in [Figure 5](#fig5){ref-type="fig"} (now in [Figure 4](#fig4){ref-type="fig"}).

*The bulk assay shown in [Figure 6](#fig6){ref-type="fig"} may be subject to effects caused by vesicle docking and/or lipid mixing since both effects would result in the observed decrease in donor fluorescence. Content mixing assays should be performed.*

We performed content mixing experiments and confirmed that there was no leakiness in content mixing experiments ([Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}).

Reviewer \#2:

*The role of patches of basic residues at the side (K326, K327) and bottom (R398, R399) of the synaptotagmin 1 C2B domain on SNARE protein/complex and phospholipid binding have been focus of numerous studies in the recent past, leading to partially conflicting results. This study aims to resolve the SNARE and membrane binding modes of the C2B domain (in absence and presence of Ca^2+^) and how these interactions contribute to the fusion process. The authors utilize a number of techniques GST pulldown, coflotation, fluorescence measurements and in vitro fusion assays to demonstrate that mutation of side and bottom basic residues impair SNARE complex binding and membrane binding in a Ca dependent manner. This work is based on a large body of literature and the findings presented here are in part confirmatory and in part new. New is the finding that the interactions of the bottom loop with the membrane can be competitively displaced by the presence of SNARE complexes. Another aspect of the work is that the authors show that synaptotagmin C2B domain is able to double the rate of SNARE complex formation. Perhaps the most interesting aspect is that they can simultaneously monitor both penetration of C2B domain into the membrane and binding to the SNARE complex with the bottom loop at the same time, providing decent proof for the presence of a simultaneous binding of top loops to membranes and bottom loop to cis-SNARE complex via the acid patch created by SNAP25 residues. However, does this experiment exclude that a considerable fraction of the bottom loop would also be able to interact with the phospholipid membrane ?*

We thank reviewer \#2 for raising this question. It is generally believed that one synaptic vesicle contains 15 copies of Syt1 molecule. Are all of these Syt1 molecules involved in binding with the SNARE complex? It is really hard to answer based on our bulk assay performed in vitro. However, we found that Syt1-dependent membrane clustering in the presence of calcium was much reduced in the presence of the SNARE complex, we also showed that the C2B2KE or C2B2KA mutations but not the C2B2RQ abolished PIP2 binding with co-flotation experiments. Furthermore, we detected the strong FRET between the bottom loop and the SNARE complex with or without Ca^2+^ in a membrane environment. These results strongly suggest that a majority fraction of the C2B bottom loop interact with the SNARE complex. To data, we could not exclude the possibility that a fraction of the bottom loop bind membranes to promote release. We discussed this possibility in the Discussion (paragraph four). Nevertheless, further work will be required to answer this question by using single molecule FRET experiments.

*On other issue here is the conversion of positive to negative charges in the mutations: net charge difference particularly in the coflotation assays may be of* concern.

We re-tested both the C2B2KE and C2B2KA mutants and the results showed that they both lost the ability to bind PIP2-containing liposomes ([Figure 2D,E](#fig2){ref-type="fig"}). Thus, we suppose that conversion of positive charges to negative or neutral charges results in similar effect. Therefore, we used the C2B2KE mutation throughout our study.

Reviewer \#3:

*This study has important new data, is largely well-written and, in certain respects, presents major advances, especially in [Figure 3](#fig3){ref-type="fig"}. 1) They \"propose that the membrane bending induced by the fast transition between the two binding modes underlies the \[fusion\] triggering function of C2B\" (from the Abstract), yet there is no measurement of membrane bending nor is there any data which implicates the transition between the two binding modes, as opposed to the binding modes themselves, in causing fusion. They are welcome to make such a model, of course, but should make clearer distinctions between what they show and what is simply hypothesis.*

Sorry for the misleading sentences in the Abstract or elsewhere in our previous manuscript. In the new one, we described our findings and our hypothesis more clearly. Briefly, our findings are i) before Ca^2+^ influx, C2B binds to the SNARE complex via the bottom R398 R399 region, and interacts with acidic membranes (containing PIP2) through the side K326 K327 region ([Figure 2](#fig2){ref-type="fig"}); ii) after Ca^2+^ influx, the R398 R399--SNARE complex interaction and the K326 K327--PIP2 interaction persist upon insertion of the Ca^2+^-binding loops into membranes ([Figure 4](#fig4){ref-type="fig"}); iii) we showed that the three binding interfaces of C2B involving the Ca^2+^-binding loops, the R398 R399 and the K326 K327 regions bound respectively to PS, PIP2 and SNARE complex in a simultaneous and synergistic manner ([Figure 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). These interactions were found to be crucial for the triggering activity of Syt1 in liposome fusion ([Figure 7](#fig7){ref-type="fig"}). Our hypothesis is that the simultaneous SNARE-containing membrane interactions of the Ca^2+^-binding loops and of the two basic regions of C2B would exert a force to deform the plasma membrane in response to Ca^2+^ ([Figure 8](#fig8){ref-type="fig"}). This hypothesis is in good agreement with a recent model proposed by Zhou et al., 2015, Nature. In addition, this hypothesis is supported by a recent observation (Bharat et al., 2014) that local membrane protrusions (5 nm in height, similar like the size of one C2B molecule) bucked on the surface of GUV require the presence of Syt1 and assembled SNARE complex.

*2) The data in [Figure 6](#fig6){ref-type="fig"} from the classical assay of dequenching between two fluorescent lipids purports to show \"lipid mixing\". However, it has been shown in this journal (Zick and Wickner, eLife 2014;3:e09251) that this assay measures trans-SNARE pair dependent events which do not correspond to lipid mixing. In the text, they assume that this lipid mixing is the result of fusion, though it was shown in this same paper that such dequenching can occur in the absence of fusion. The authors should replace this figure with one measuring the mixing of proteoliposomal lumenal contents (in the continuous presence of an external quenching agent, to control for leakage or lysis).*

We performed content mixing experiments and confirmed that there was no leakiness in our content mixing experiments (see [Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). We thank the reviewer for suggesting this robust assay (Zick and Wickner, *eLife* 2014) that has been widely used to measure content mixing. We will definitely try to apply this assay to our future studies.

*3) They claim that calcium binding \"...causes a cooperative interaction of C2B with membranes and the SNARE complex.\" The data however show that C2B can bind membranes or SNARE complex independently, with no data showing cooperativity to this binding.*

We showed that C2B can bind membranes or SNARE complexes independently in the absence of Ca^2+^ ([Figure 2](#fig2){ref-type="fig"}), and showed C2B can bind synergistically ([Figure 3](#fig3){ref-type="fig"}) and simultaneously ([Figure 4](#fig4){ref-type="fig"}) to membranes and SNARE complexes in the presence of Ca^2+^. We agree with reviewer \#3 that we had no enough data to declare the "cooperative" behavior among C2B, SNARE complexes and membranes, we thus changed "cooperativity" to "synergistically" throughout the manuscript.

*4) [Figure 2A](#fig2){ref-type="fig"}; they claim that C2B but not C2A binds to SNARE complex, but the C2B band is faint and the C2A band could be just below the detection limit. Also, they claim synergy between the 2 basic regions of C2B for their binding to SNARE complex, but there is no quantitative binding data to gird this claim. What do they mean by synergy here?*

Our GST pull-down experiments showed that, compared to C2A, either C2B or C2AB exhibited stronger binding to the SNARE complex. The binding between C2A and the SNARE complex might be too weak to be detected in our GST pull-down assay (we noted this in the paper). However, we agree that we could not exclude the possibility that C2A also interacts with the SNARE complex and plays a role in release. Besides, we deleted the sentence claiming the binding synergy of the two basic regions of C2B with the SNARE complex.

*5) Does \"MUN\", as used in [Figure 3](#fig3){ref-type="fig"}, refer to both Munc13 and Munc18? Were these singly omitted, to support the claim that both are needed? I don\'t see this in the figure.*

As editors suggested, we removed the Munc13 part and only focused on the Syt1--SNARE complex--membrane interaction in the current manuscript.

\[Editors\' note: the author responses to the re-review follow.\]

Essential revisions:

1\) The pull-down assay shown in [Figure 2A](#fig2){ref-type="fig"} is used as a basis to claim that mutation of the acidic patch in the SNARE complex (SNAP-25 D51/E52/E55 to A -- 3M) abolishes binding to the Syt-1 C2B domain. However, it looks as if there is much less SNARE complex in this assay. The authors claim that this is due to lower SDS-resistance of the 3M complex, but there is no trace of the SNARE monomers on the gel, and there is a (slight) difference in the assembly between the WT and the 3M complex. How can one be sure that the same amount of assembled SNARE complex was added in the assay?

We analyzed the overnight-assembled GST-tagged SNARE complex WT and 3M by SDS-PAGE ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The result show that the SNARE complex 3M is less resistant to SDS compared to the SNARE complex WT before boiling, whereas the individual SNAREs of 3M are same to that of WT after boiling. These results confirm the same amount of assembled SNARE complex was added in our experiments.

*2) [Figure 3](#fig3){ref-type="fig"}: In their binding assays designed to show the synergistic effects of the three key Syt-1 C2B binding modes, the authors used a condition where the dominant effect of the calcium-dependent interaction is reduced. How sensitive are the interactions to calcium (see also next point)?*

Previous [Figure 3](#fig3){ref-type="fig"} is current [Figure 5](#fig5){ref-type="fig"}; and previous [Figure 4](#fig4){ref-type="fig"} is current [Figure 6](#fig6){ref-type="fig"}. As shown in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, we monitored the sensitivity of the binding between C2B and PS-containing liposomes in different Ca^2+^ concentrations. Binding of C2B with liposomes decreased as the Ca^2+^ concentration declined. When the concentration of Ca^2+^ was below 0.1 mM, we could not detect the binding between C2B and PS-containing liposomes with SDS-PAGE gel.

3\) [Figure 3](#fig3){ref-type="fig"} implies that there is no interaction between C2B and the membrane-reconstituted SNARE complex in the absence of calcium and absence of PIP2. Yet, [Figure 4 F-I](#fig4){ref-type="fig"} suggests that there is such an interaction in the absence of calcium and presence of PIP2. The authors should attempt a co-flotation experiment using the same conditions as that of [Figure 4F-I](#fig4){ref-type="fig"}, and in the absence of calcium.

To reduce the dominate effect of the Ca^2+^-dependent interaction between C2B and PS and for better monitoring the synergistic effects among the three key Syt-1 C2B binding modes, we used the buffer with higher ion strength (250 mM KCl) and 0.1 mM Ca^2+^ throughout the experiments in [Figure 5](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. In contrast, the buffer we used for those experiments in [Figure 6](#fig6){ref-type="fig"} and other figures contains 150 mM KCl instead (we noted this in subsection "Ca2+-dependent interactions of C2B to SNARE complexes and acidic membranes"). The salt concentration differences (250 mM v.s. 150 mM) may explain why the C2B--SNARE complex binding could be detected in [Figure 6](#fig6){ref-type="fig"} but not in [Figure 5](#fig5){ref-type="fig"}.

Nevertheless, we still performed the co-flotation experiment the reviewers suggested to confirm the interaction between C2B and the membrane-reconstituted SNARE complex using the same conditions as that of [Figure 6 F-I](#fig6){ref-type="fig"} (in the presence of 150 mM KCl with and without 0.1 mM Ca^2+^). Please see the figure below; note we did not include this figure in the manuscript).

In this figure, fractions 1 to 6 represent proteins distributed from the top (C2B bound to liposomes) to the bottom (C2B in the pellet) of the density gradients of the co-flotation sample after centrifuge. Liposome compositions are indicated.

Consistent with our prediction, these results show C2B binds to the membrane-embedded SNARE complex but not to plain liposomes in the absence of Ca^2+^ (0.2 mM EDTA) and in the presence of 0.1 mM Ca^2+^, confirming the C2B--SNARE complex interaction in the presence of 150 mM KCl observed in [Figure 6 F-I](#fig6){ref-type="fig"}.

4\) [Figure 4](#fig4){ref-type="fig"}: Syt1-T285W and SNAP-25 R59C mutations. The authors should comment in the text that these residues are outside the primary interface between Syt1 and SNARE complex as observed in the crystal structures by Zhou et al. (2015). Thus, these mutations are unlikely going to affect this particular interaction between Syt1 and SNARE complex. This is an important comment since unfortunate placement of labels have affected this interaction in work by others (Brewer et al., 2015; Park et al., 2015). Moreover, the Ca-Ca distance between the two labeling sites is \~ 12 A (based on the structures by Zhou et al.), consistent with the relatively large effect on FRET that the authors observe. Again, this is worth mentioning.

We thank the reviewers for providing these useful comments. We added them in the text (Discussion section paragraph three).

5\) [Figure 6](#fig6){ref-type="fig"}: Was this experiment done in the presence of membrane (i.e., similar to the method shown in [Figure 4F-I](#fig4){ref-type="fig"})?

Previous [Figure 6](#fig6){ref-type="fig"} is current [Figure 3](#fig3){ref-type="fig"}. By using the bimane-tryptophan quenching assay, we performed the experiments of [Figure 3](#fig3){ref-type="fig"} to confirm the maintenance of the R398 R399--SNARE complex interaction in the absence of membranes and in the presence of ATP and Mg^2+^. To avoid the confusion, we change the word "in solution" with "in the absence of membranes".

6\) [Figure 7](#fig7){ref-type="fig"} and second paragraph subsection "Ca^2+^-dependently simultaneous C2B--SNARE complex--membrane interactions are crucial for triggering fusion": The in vitro assay by Kyoung et al., 2011; Diao et al., 2012; Lai et al., 2014) actually reconstituted the full-length Syt1-SNARE machinery at physiological Syt1 copy number and also included complexin. Moreover, Zhou et al. (2015) showed that mutation of the primary interface disrupts calcium-triggered vesicle fusion in this assay. These results should be mentioned in the context of presenting [Figure 7](#fig7){ref-type="fig"} and the authors should point out which aspects of their experiments go beyond the previous results by Zhou et al. (2015) (e.g., the studies of calcium-binding site mutations.

We mentioned these papers and pointed out the aspects that go beyond the previous results (Results section).

7\) [Figure 7](#fig7){ref-type="fig"}: Based on other work (Wang Z, Liu H, Gu Y, Chapman ER (2011) Reconstituted synaptotagmin I mediates vesicle docking, priming, and fusion. J Cell Biol 195:1159-70. doi: 10.1083/jcb.201104079) the behaviors of the isolated Syt-1 C2B or Syt-1 C2AC2B fragments are different from the behavior of full-length Syt-1. The authors need to validate the findings in [Figure 7](#fig7){ref-type="fig"} that go beyond those of Zhou et al. (2015) by using full-length, reconstituted Syt-1.

We have validated the functional difference of Syt1 C2A and C2B domain using reconstituted full-length Syt1 (Figure 7---figure supplement 4, and in the final paragraph of the Results section).

8\) [Figure 8](#fig8){ref-type="fig"}: the palmitoylation positions of the SNAP-25 linker region are incorrectly drawn -- they are close to the C-terminal side of the SNARE complex.

We thank the reviewers for pointing out this mistake. We revised it accordingly ([Figure 8](#fig8){ref-type="fig"}).

*9) Please provide the rationale for the (relative) concentrations of SNAREs, SNARE complexes, and Syt-1 fragments used in the different assays.*

All SNAREs or SNARE complex-reconstituted liposomes were prepared with a protein-to-lipid ratio of 1:200 as reported (Lai et al., 2014, *eLife*). For GST pull-down and liposome co-flotation assays, excess of the Syt1 fragments (10 μM) were used in order to saturate the binding. For lipid mixing, content mixing ([Figure 7](#fig7){ref-type="fig"}) and SNARE paring assays ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}), equivalent amount of the Syt1 fragments (0.5 μM) compared to syntaxin-1--SNAP-25 complex (0.5 μM) reconstituted on liposomes were used to avoid liposome cluster during calcium incorporation. For fluorescent measurements, especially FRET-based assays, the Syt1 fragments as a donor ([Figure 2F,G](#fig2){ref-type="fig"}) were added to 5 μM in order to monitor the acceptor (rodamine) fluorescence as reported (Hui et al., 2011, NSMB); the Syt1 fragments as an acceptor (for all bimane-tryptophan quenching assays in the manuscript) were added to 5 μM for saturating the FRET, as demonstrated in the titration experiment in [Figure 4](#fig4){ref-type="fig"}. For liposome cluster assay in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, excess of Syt1 fragments (10 μM) were used for monitoring liposome cluster as reported (Arac et al., 2006, NSMB and Xue et al., 2008, NSMB). More details are described in the Materials and methods section.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

The manuscript has been improved but there are some small remaining issues that need to be addressed before acceptance, as outlined below:

1\) Please move the new results with full-length synaptotagmin^-1^ to the main figure and move the results with the soluble C2AB domain ([Figure 7](#fig7){ref-type="fig"}) to a supplement. The results with the full-length protein are more relevant.

We agree with the reviewers that the results with the full-length Syt1 are more relevant and we thus have moved the related results to the main figure (see [Figure 8](#fig8){ref-type="fig"}). In addition, we still keep the [Figure 7](#fig7){ref-type="fig"} in the main figures because we think the data obtained in such a more simplified fusion system (with C2B or C2A) is also important for understanding the triggering function of C2B. Both of the C2AB-based and full-length Syt1-based fusion systems well reproduced the functional importance of the C2B domain observed in vivo. Beside, the working model for Syt1 (previous [Figure 8](#fig8){ref-type="fig"}) is moved to [Figure 9](#fig9){ref-type="fig"}.

2\) Results, paragraph one: \"K326E/K327E, K326E/K327E\" should be \"K326A/K327A, K326E/K327E\".

We thank the reviewers for careful reading of the manuscript and we revised it as suggested.
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